An Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Chen, Christine I. [1 ]
Paul, Harminder [1 ]
Snitzler, Susi [1 ]
Le, Lisa W. [2 ]
Wei, Ellen Nong [1 ]
Lau, Anthea [2 ]
Johnston, James B. [3 ]
Gibson, Spencer B. [4 ]
Queau, Michelle L. [4 ]
Trudel, Suzanne [1 ]
机构：
[1] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
[3] Canc Care Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada
[4] Canc Care Manitoba, Res Inst Oncol & Hematol, Winnipeg, MB, Canada
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Preliminary Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL)
    Lampson, Benjamin L.
    Tyekucheva, Svitlana
    Crombie, Jennifer L.
    Kim, Austin I.
    Merryman, Reid W.
    Lowney, Jessica
    Montegaard, Josie
    Patterson, Victoria
    Jacobson, Caron A.
    Jacobsen, Eric D.
    LaCasce, Ann S.
    Arnason, Jon E.
    Armand, Philippe
    Fisher, David C.
    Brown, Jennifer R.
    Davids, Matthew S.
    BLOOD, 2019, 134
  • [32] Final Analysis of a Phase 2 Study of Lenalidomide and Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
    Badoux, Xavier C.
    Keating, Michael J.
    O'Brien, Susan
    Wierda, William G.
    Faderl, Stefan
    Estrov, Zeev
    Pasia, Manolo
    Lerner, Susan
    Sargent, Rachel L.
    Kantarjian, Hagop M.
    Ferrajoli, Alessandra
    BLOOD, 2011, 118 (21) : 448 - 448
  • [33] Combination Therapy with Ofatumumab and Lenalidomide in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): Results of a Phase II Trial
    Ferrajoli, Alessandra
    O'Brien, Susan
    Wierda, William G.
    Faderl, Stefan
    Badoux, Xavier
    Estrov, Zeev
    Schlette, Ellen
    Smith, Susan C.
    Ayala, Ana B.
    Falchi, Lorenzo
    Calin, Steliana
    Kantarjian, Hagop M.
    Keating, Michael J.
    BLOOD, 2011, 118 (21) : 780 - 780
  • [34] A Combination of Fludarabine/Rituximab with Escalating Doses of Lenalidomide in Previously Untreated Chronic Lymphocytic Leukemia (CLL): The REVLIRIT CLL5 AGMT Phase I/II Study, Clinical and Exploratory Analyses of Induction Results
    Egle, Alexander
    Steurer, Michael
    Gassner, Franz
    Geisberger, Roland
    Melchardt, Thomas
    Weiss, Lukas
    Fridrik, Michael A.
    Thaler, Josef
    Lang, Alois
    Greil, Richard
    BLOOD, 2011, 118 (21) : 135 - 136
  • [35] A Phase 2 Study of Ofatumumab in Combination with a Pan-AKT Inhibitor (Afuresertib) in Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine I.
    Snitzler, Susi
    Levina, Olga
    Wang, Tong
    Le, Lisa W.
    Paul, Harminder
    Wei, Ellen Nong
    Lau, Anthea
    Queau, Michelle
    Johnston, James B.
    Trudel, Suzanne
    Smith, Deborah A.
    BLOOD, 2015, 126 (23)
  • [36] Phase 3 Trial of Acalabrutinib in Combination with Venetoclax, With and Without Obinutuzumab Versus Chemoimmunotherapy for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
    Brown, Jennifer R.
    Eichhorst, Barbara
    Ghia, Paolo
    Kater, A. P.
    Li, Jianyong
    Khurana, Sudha
    Elhamy, Mostafa
    Wang, Min Hui
    Seymour, John F.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S221 - S222
  • [37] Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
    Chen, Christine I.
    Bergsagel, P. Leif
    Paul, Harminder
    Xu, Wei
    Lau, Anthea
    Dave, Nimisha
    Kukreti, Vishal
    Wei, Ellen
    Leung-Hagesteijn, Chungyee
    Li, Zhi Hua
    Brandwein, Joseph
    Pantoja, Mariela
    Johnston, James
    Gibson, Spencer
    Hernandez, Tiffany
    Spaner, David
    Trudel, Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : 1175 - 1181
  • [38] CAMPATH-1H therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
    Lundin, J
    Björkholm, M
    Celsing, F
    Hale, G
    Hjalmar, V
    Kimby, E
    Tullgren, O
    Waldman, H
    Mellstedt, H
    Österborg, A
    ANNALS OF ONCOLOGY, 2000, 11 : 96 - 96
  • [39] CAMPATH-1H therapy of patients with previously untreated chronic lymphocytic leukemia (CLL).
    Mellstedt, H
    Österborg, A
    Lundin, J
    Björkholm, M
    Celsing, F
    Hagberg, H
    Hast, R
    Hjalmar, V
    Kimby, E
    Luthman, M
    Tullgren, O
    Werner, B
    BLOOD, 1998, 92 (10) : 490A - 490A
  • [40] A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
    William, Basem M.
    Brillhart, Kaylee
    Afable, Manuel
    Bakalarz, Kristen
    Cooper, Brenda
    Lazarus, Hillard M.
    Gerson, Stanton L.
    Creger, Richard
    Nagabhushanam, Kalyanam
    Grote, James
    Fu, Pingfu
    Kunati, Sandeep
    Yang, Shuming
    Xu, Yan
    Woost, Philip
    Jacobberger, James
    de Lima, Marcos
    Caimi, Paolo
    BLOOD, 2018, 132
12345